Salt Lake City, UT ( Thursday Oct 19, 2023 @ 7:00 AM Australia/Perth —

TMS Solutions, a leading company specializing in Transcranial Magnetic Stimulation (TMS) therapy, is providing individuals suffering from depression with an innovative and effective treatment option. TMS therapy uses magnetic pulses to stimulate neurons in the brain, leading to a reduction or elimination of depression symptoms.

Utilizing state-of-the-art technology, TMS therapy offers a drug-free, non-invasive, and non-systemic approach for depression treatment. Unlike other options, TMS therapy does not require sedation or anesthesia, ensuring a comfortable and hassle-free experience for patients.

“At TMS Solutions, we prioritize the safety and well-being of our patients,” said Christopher Blackburn, Founder of TMS Solutions. “Our FDA-cleared treatment has been scientifically proven to alleviate depression symptoms without the harmful side effects often associated with traditional approaches.”

With an exceptional success rate, TMS Solutions is proud to report that 73% of their patients have experienced at least a 50% reduction in symptoms, while over 49% have achieved complete remission. The therapy has proven to be transformative for countless individuals, providing a newfound sense of hope and improved quality of life.

Affordability and accessibility are key factors in TMS Solutions’ commitment to helping their patients. The company ensures that TMS therapy is covered by most major medical insurance companies, Medicare, and the VA’s PTSD treatment for veterans program. This ensures that individuals have access to this groundbreaking treatment without facing financial burdens.

As a patient-centered clinic, TMS Solutions offers personalized care with a one-on-one technician-to-patient ratio and evaluations conducted by licensed providers. Since 2014, the company has successfully administered over 80,000 treatments, solidifying its expertise and commitment to delivering outstanding patient care.

TMS Solutions is also proud to be the only civilian TMS provider pre-qualified by the VA to treat veterans nationwide, further highlighting their dedication to serving those who have served their country. Moreover, they have been selected by the FDA as one of ten nationwide providers for an adolescent clinical trial, showcasing their commitment to advancing medical breakthroughs.

This press release is distributed by the™ Press Release Newswire – News Marketing Platform™. Reference URL for this press release is here.